Correlation Between Jinhe Biotechnology and BeiGene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and BeiGene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and BeiGene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jinhe Biotechnology Co and BeiGene, you can compare the effects of market volatilities on Jinhe Biotechnology and BeiGene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of BeiGene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and BeiGene.

Diversification Opportunities for Jinhe Biotechnology and BeiGene

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Jinhe and BeiGene is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and BeiGene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BeiGene and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with BeiGene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BeiGene has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and BeiGene go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and BeiGene

Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to under-perform the BeiGene. In addition to that, Jinhe Biotechnology is 1.33 times more volatile than BeiGene. It trades about -0.07 of its total potential returns per unit of risk. BeiGene is currently generating about 0.24 per unit of volatility. If you would invest  16,157  in BeiGene on October 20, 2024 and sell it today you would earn a total of  2,061  from holding BeiGene or generate 12.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Jinhe Biotechnology Co  vs.  BeiGene

 Performance 
       Timeline  
Jinhe Biotechnology 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology may actually be approaching a critical reversion point that can send shares even higher in February 2025.
BeiGene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BeiGene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BeiGene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Jinhe Biotechnology and BeiGene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jinhe Biotechnology and BeiGene

The main advantage of trading using opposite Jinhe Biotechnology and BeiGene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, BeiGene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will offset losses from the drop in BeiGene's long position.
The idea behind Jinhe Biotechnology Co and BeiGene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format